{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:40:47Z","timestamp":1780958447403,"version":"3.54.1"},"reference-count":31,"publisher":"Cambridge University Press (CUP)","issue":"7","license":[{"start":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T00:00:00Z","timestamp":1586908800000},"content-version":"unspecified","delay-in-days":2053,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["europsy-journal.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Eur. psychiatr."],"published-print":{"date-parts":[[2014,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S092493380024474X_abs1\" sec-type=\"intro\"><jats:title>Introduction<\/jats:title><jats:p>Low levels of blood cholesterol have been found in some children with autism spectrum disorders (ASD). Psychotropic medications, commonly used by people with ASD and people with intellectual disabilities (ID) are frequently associated with altered metabolic profiles.<\/jats:p><\/jats:sec><jats:sec id=\"S092493380024474X_abs2\" sec-type=\"other\"><jats:title>Purpose<\/jats:title><jats:p>We aimed to compare metabolic features of adults with ASD or ID with those of a community-based population.<\/jats:p><\/jats:sec><jats:sec id=\"S092493380024474X_abs3\" sec-type=\"methods\"><jats:title>Subjects and methods<\/jats:title><jats:p>Data on blood fasting glucose (FBG), lipid profile, liver enzyme profile, TSH, BMI, medications and diagnoses of 80 adults with ASD, 77 adults with ID and 828 control adults were drawn from medical charts\/database. Candidates that used glucose or lipid lowering medications were not included.<\/jats:p><\/jats:sec><jats:sec id=\"S092493380024474X_abs4\" sec-type=\"results\"><jats:title>Results<\/jats:title><jats:p>Total-cholesterol levels of people with ASD and ID were significantly lower than those of the controls (168.3 \u00b1 32.78, 168.2 \u00b1 32.91, 185.4 \u00b1 40.49 mg\/dL, respectively,<jats:italic>P<\/jats:italic>&lt; 0.001) but after adjusting for gender, age and BMI and using Bonferroni correction, the significance was lost. Compared to controls, ASD and ID had significantly lower FBG (by \u201314.45 \u00b1 1.81, \u201314.58 \u00b1 1.54 mg\/dl, respectively;<jats:italic>P<\/jats:italic>&lt; 0.001 for both) and liver enzymes, despite using psychotropic medications.<\/jats:p><\/jats:sec><jats:sec id=\"S092493380024474X_abs5\" sec-type=\"discussion\"><jats:title>Discussion and conclusion<\/jats:title><jats:p>In contrast to other psychiatric patients receiving similar medications, people with ASD and ID have unaltered lipid profiles and lower glucose and liver enzyme levels compared to a community-based population.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.eurpsy.2013.05.005","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T13:30:50Z","timestamp":1373376650000},"page":"397-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Metabolic profiles in adults with autism spectrum disorder and intellectual disabilities"],"prefix":"10.1017","volume":"29","author":[{"given":"L.","family":"Moses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2020,4,15]]},"reference":[{"key":"S092493380024474X_bib0040","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0112"},{"key":"S092493380024474X_bib0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.nutres.2010.04.002"},{"key":"S092493380024474X_bib0100","doi-asserted-by":"publisher","DOI":"10.1021\/pr300910n"},{"key":"S092493380024474X_bib0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(99)00126-2"},{"key":"S092493380024474X_bib0150","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.b.30368"},{"key":"S092493380024474X_bib0115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2788.1992.tb00535.x"},{"key":"S092493380024474X_bib0025","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-002-0367-4"},{"key":"S092493380024474X_bib0095","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2006.0126"},{"key":"S092493380024474X_bib0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2012.04.010"},{"key":"S092493380024474X_bib0145","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03068.x"},{"key":"S092493380024474X_bib0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5618.2007.00534.x"},{"key":"S092493380024474X_bib0005","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.11.2121"},{"key":"S092493380024474X_bib0035","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.01.014"},{"key":"S092493380024474X_bib0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2007.05.005"},{"key":"S092493380024474X_bib0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00345-X"},{"key":"S092493380024474X_bib0105","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6081.226"},{"key":"S092493380024474X_bib0070","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(03)00166-6"},{"key":"S092493380024474X_bib0130","doi-asserted-by":"publisher","DOI":"10.3109\/00365517909106135"},{"key":"S092493380024474X_bib0155","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1617-6"},{"key":"S092493380024474X_bib0110","doi-asserted-by":"publisher","DOI":"10.1007\/BF02178193"},{"key":"S092493380024474X_bib0125","doi-asserted-by":"publisher","DOI":"10.1007\/s004060200001"},{"key":"S092493380024474X_bib0060","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1176\/ajp.156.8.1270","article-title":"Clozapine-associated elevation in serum triglycerides","volume":"156","author":"Gaulin","year":"1999","journal-title":"Am J Psychiatry"},{"key":"S092493380024474X_bib0140","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(99)00157-1"},{"key":"S092493380024474X_bib0090","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2826-4"},{"key":"S092493380024474X_bib0065","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1176\/ajp.152.3.419","article-title":"Low serum cholesterol level and attempted suicide","volume":"152","author":"Golier","year":"1995","journal-title":"Am J Psychiatry"},{"key":"S092493380024474X_bib0135","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.31294"},{"key":"S092493380024474X_bib0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.ridd.2009.12.002"},{"key":"S092493380024474X_bib0120","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-006-9160-4"},{"key":"S092493380024474X_bib0050","doi-asserted-by":"publisher","DOI":"10.1089\/10507250252949405"},{"key":"S092493380024474X_bib0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2006.02.003"},{"key":"S092493380024474X_bib0085","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.290"}],"container-title":["European Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933813000710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924933813000710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S092493380024474X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:05:58Z","timestamp":1688342758000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S092493380024474X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S092493380024474X"],"URL":"https:\/\/doi.org\/10.1016\/j.eurpsy.2013.05.005","relation":{},"ISSN":["0924-9338","1778-3585"],"issn-type":[{"value":"0924-9338","type":"print"},{"value":"1778-3585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic profiles in adults with autism spectrum disorder and intellectual disabilities","name":"articletitle","label":"Article Title"},{"value":"European Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurpsy.2013.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}